Lydia I. Ilyenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lydia I. Ilyenko has a total of 134 co-authors. Here are the top co-authors by number of shared publications:
- Natalia V. Orlova
N. I. Pirogov Russian National Research Medical University (Pirogov University)
14 shared publications - O. A. Tiganova
N. I. Pirogov Russian National Research Medical University (Pirogov University)
6 shared publications - Svetlana V. Bogdanova
Pirogov Russian National Research Medical University
6 shared publications - Yana G. Spiryakina
N. I. Pirogov Russian National Research Medical University (Pirogov University)
6 shared publications Я. Г. Спирякина
ФГАОУ ВО «Российский национальный исследовательский медицинский университет имени Н. И. Пирогова» Минздрава России (Пироговский университет)
6 shared publications- Natalia D. Karseladze
NAKFF Medical Clinic LLC
5 shared publications
Latest Publications
- Open Access
- 25 October 2026
- Published by Alfmed LLC in Medical alphabet
- No. 22,p. 68-75
Genetic markers of cardiotoxicity associated with anticancer therapy
The improvement in survival rates for most malignant neoplasms (MNOs) poses a challenge to healthcare in terms of longterm complications of antitumor chemotherapy (ATC). The clinical manifestations of ATC complications affecting various organs are nonspecific, which makes their diagnosis difficult, especially against the background of the course of the underlying MNO. The longterm consequences of ATC administered in childhood may manifest themselves years or even decades later. Doctors across a wide range of specialties need knowledge in the field of pharmacogenetics of chemotherapy drugs, as well as in the clinical manifestations of these drugs, including delayed ones, due to the possibility of adverse effects of chemotherapy on various organs and systems. Due to the use of cardiotoxic drugs in the treatment of malignant neoplasms in childhood, there is a risk of longterm adverse effects on the cardiovascular system.
- 25 October 2026
- Published by Alfmed LLC in Medical alphabet
- No. 22,p. 68-75
Open AccessGenetic markers of cardiotoxicity associated with anticancer therapy
The improvement in survival rates for most malignant neoplasms (MNOs) poses a challenge to healthcare in terms of longterm complications of antitumor chemotherapy (ATC). The clinical manifestations of ATC complications affecting various organs are nonspecific, which makes their diagnosis difficult, especially against the background of the course of the underlying MNO. The longterm consequences of ATC administered in childhood may manifest themselves years or even decades later. Doctors across a wide range of specialties need knowledge in the field of pharmacogenetics of chemotherapy drugs, as well as in the clinical manifestations of these drugs, including delayed ones, due to the possibility of adverse effects of chemotherapy on various organs and systems. Due to the use of cardiotoxic drugs in the treatment of malignant neoplasms in childhood, there is a risk of longterm adverse effects on the cardiovascular system.
- Open Access
- 25 October 2026
- Published by Alfmed LLC in Medical alphabet
- No. 22,p. 44-51
Genetic assessment of high risk of complications in the maternal–placental–fetal system in hypertensive disorders in pregnant women
Arterial hypertension (AH) is the most common extragenital pathology, which is recorded in every tenth pregnant woman worldwide. In the Russian Federation, the prevalence of AH in pregnant women is even higher, amounting to 7–30 %, and is responsible for 20–25 % of perinatal mortality. Scientific literature has identified more than 1,500 genetic polymorphisms associated with various blood pressure regulation mechanisms. The complex regulation of blood pressure and the multifactorial pathogenesis of hypertension, which are influenced by various genes, suggest that the prognostic significance of genetic analysis may be enhanced by taking into account the combined effect of polymorphisms in different genes. Currently, more than 60 genes have been identified based on the pathophysiology of preeclampsia that may influence the development of preeclampsia. Indications for prescribing a genetic test may include: a history of preeclampsia or cases in close relatives, elevated blood pressure during a previous pregnancy, planning a pregnancy, pregnancy against the background of diabetes, kidney diseases, autoimmune pathologies, excess body weight, as well as a first pregnancy after the age of 40. Thus, genetic assessment of the predisposition to preeclampsia can be a useful tool in medicine for early prediction and prevention of pregnancy complications.
- 25 October 2026
- Published by Alfmed LLC in Medical alphabet
- No. 22,p. 44-51
Open AccessGenetic assessment of high risk of complications in the maternal–placental–fetal system in hypertensive disorders in pregnant women
Arterial hypertension (AH) is the most common extragenital pathology, which is recorded in every tenth pregnant woman worldwide. In the Russian Federation, the prevalence of AH in pregnant women is even higher, amounting to 7–30 %, and is responsible for 20–25 % of perinatal mortality. Scientific literature has identified more than 1,500 genetic polymorphisms associated with various blood pressure regulation mechanisms. The complex regulation of blood pressure and the multifactorial pathogenesis of hypertension, which are influenced by various genes, suggest that the prognostic significance of genetic analysis may be enhanced by taking into account the combined effect of polymorphisms in different genes. Currently, more than 60 genes have been identified based on the pathophysiology of preeclampsia that may influence the development of preeclampsia. Indications for prescribing a genetic test may include: a history of preeclampsia or cases in close relatives, elevated blood pressure during a previous pregnancy, planning a pregnancy, pregnancy against the background of diabetes, kidney diseases, autoimmune pathologies, excess body weight, as well as a first pregnancy after the age of 40. Thus, genetic assessment of the predisposition to preeclampsia can be a useful tool in medicine for early prediction and prevention of pregnancy complications.
- Open Access
- 2 December 2025
- Published by Alfmed LLC in Medical alphabet
- No. 36,p. 42-46
Complications of pregnancy, childbirth, and fetal pathology in pregnant women with hypertensive disorders
Arterial hypertension in pregnant women increases the risk of complications of pregnancy, childbirth, fetal and newborn pathology. A survey of 80 pregnant women and EMIAS data was conducted. Elevated blood pressure during office measurement was recorded in 31 patients, according to the SMAD data, 20 pregnant women with arterial hypertension were identified. According to the results of the study, in 55 % of pregnant women, gestational hypertension was confirmed in patients with office blood pressure levels within the normal range. Thus, the use of SMAD increases the detection of hypertension in pregnant women by two times. Unjustified prescribing of antihypertensive drugs to pregnant women with an office increase in blood pressure, but with unconfirmed hypertension using the SMAD method (50 %) was noted. A low level of antihypertensive drug use was revealed in pregnant women with confirmed arterial hypertension according to SMAD (35 %). The following results were obtained from the study of the daily blood pressure profile of pregnant women with hypertension: arterial hypertension was observed during the day in 26.7 %, during waking hours in 6.7 %, and at night in 66.7 %. The average daytime SAD was increased in 26.6 % of pregnant women with hypertension, and the average nighttime SAD was increased in 50 %. The average daily SAD was increased in 30 %. The average daily DBP was increased in 50 % of pregnant women, no increase in nocturnal DBP was noted. An increase in VUP SAD was noted in 3.33 %, an increase in VUP DAD – in 10 %. The rate of morning SAD rise was within the normal range in 66.7 % of pregnant women with hypertension, increased – 33.3 %, the rate of morning DBP rise was within the normal range in 53.3 % of pregnant women with hypertension, increased – 46.7 %. PAD was within the normal range in 63.3 % of pregnant women with hypertension, exceeded the norm – in 36.7 %. The variability of SAD and DBP was within the normal range (daily index of 10–20 %).Obese patients in most cases show an increase in blood pressure numbers during routine blood pressure measurements, as well as a high risk of preeclampsia. Pregnant women with hypertension have a high risk of preeclampsia, gestational diabetes mellitus, anemia, and gestational pyelonephritis. In the presence of hypertension during pregnancy, the frequency of cesarean section, premature discharge of amniotic fluid/ membranes, ruptures of the cervix/perineum, fetal distress, and the risk of having a low birth weight child increases.
- 2 December 2025
- Published by Alfmed LLC in Medical alphabet
- No. 36,p. 42-46
Open AccessComplications of pregnancy, childbirth, and fetal pathology in pregnant women with hypertensive disorders
Arterial hypertension in pregnant women increases the risk of complications of pregnancy, childbirth, fetal and newborn pathology. A survey of 80 pregnant women and EMIAS data was conducted. Elevated blood pressure during office measurement was recorded in 31 patients, according to the SMAD data, 20 pregnant women with arterial hypertension were identified. According to the results of the study, in 55 % of pregnant women, gestational hypertension was confirmed in patients with office blood pressure levels within the normal range. Thus, the use of SMAD increases the detection of hypertension in pregnant women by two times. Unjustified prescribing of antihypertensive drugs to pregnant women with an office increase in blood pressure, but with unconfirmed hypertension using the SMAD method (50 %) was noted. A low level of antihypertensive drug use was revealed in pregnant women with confirmed arterial hypertension according to SMAD (35 %). The following results were obtained from the study of the daily blood pressure profile of pregnant women with hypertension: arterial hypertension was observed during the day in 26.7 %, during waking hours in 6.7 %, and at night in 66.7 %. The average daytime SAD was increased in 26.6 % of pregnant women with hypertension, and the average nighttime SAD was increased in 50 %. The average daily SAD was increased in 30 %. The average daily DBP was increased in 50 % of pregnant women, no increase in nocturnal DBP was noted. An increase in VUP SAD was noted in 3.33 %, an increase in VUP DAD – in 10 %. The rate of morning SAD rise was within the normal range in 66.7 % of pregnant women with hypertension, increased – 33.3 %, the rate of morning DBP rise was within the normal range in 53.3 % of pregnant women with hypertension, increased – 46.7 %. PAD was within the normal range in 63.3 % of pregnant women with hypertension, exceeded the norm – in 36.7 %. The variability of SAD and DBP was within the normal range (daily index of 10–20 %).Obese patients in most cases show an increase in blood pressure numbers during routine blood pressure measurements, as well as a high risk of preeclampsia. Pregnant women with hypertension have a high risk of preeclampsia, gestational diabetes mellitus, anemia, and gestational pyelonephritis. In the presence of hypertension during pregnancy, the frequency of cesarean section, premature discharge of amniotic fluid/ membranes, ruptures of the cervix/perineum, fetal distress, and the risk of having a low birth weight child increases.
- Open Access
- 2 December 2025
- Published by Alfmed LLC in Medical alphabet
- No. 36,p. 47-51
Microcirculation disorders in pregnant women with arterial hypertension and risks of infectious complications in newborns
Neonatal sepsis is the main cause of neonatal mortality. Low birth weight, premature birth, arterial hypertension of pregnant women increase the risk of neonatal sepsis and an unfavorable outcome. Premature infants and low birth weight infants often have neutropenia, which increases the risk of infection and worsens the course of bacterial infection. Neutropenia is more common in newborns from mothers with arterial hypertension of pregnant women than in children from normotensive pregnancy. Arterial hypertension in pregnant women leads to impaired remodeling of spiral arteries and changes in microvessels in the placental bed. The inability to transform the uteroplacental spiral arteries is believed to underlie pregnancy disorders, including preeclampsia and fetal growth retardation. Modern diagnostic methods such as capillaroscopy allow noninvasively assessing the state of the microcirculatory system. The risk of infection of the fetus and newborn is influenced by the microbiome of a pregnant woman, changes in which can lead to a decrease in adaptive immunity, vascular dysfunction and eclampsia. The results of the conducted studies indicate that arterial hypertension in pregnant women is associated with the risk of premature birth and low birth weight, placental insufficiency, neutropenia of newborns, changes in the microbiome, and microcirculatory disorders. Each of these factors increases the risk of neonatal sepsis and affects the outcome of the disease. Blood pressure monitoring can be considered as a preventive measure not only for eclampsia and other complications of pregnancy and childbirth, but also for the prevention of neonatal sepsis.
- 2 December 2025
- Published by Alfmed LLC in Medical alphabet
- No. 36,p. 47-51
Open AccessMicrocirculation disorders in pregnant women with arterial hypertension and risks of infectious complications in newborns
Neonatal sepsis is the main cause of neonatal mortality. Low birth weight, premature birth, arterial hypertension of pregnant women increase the risk of neonatal sepsis and an unfavorable outcome. Premature infants and low birth weight infants often have neutropenia, which increases the risk of infection and worsens the course of bacterial infection. Neutropenia is more common in newborns from mothers with arterial hypertension of pregnant women than in children from normotensive pregnancy. Arterial hypertension in pregnant women leads to impaired remodeling of spiral arteries and changes in microvessels in the placental bed. The inability to transform the uteroplacental spiral arteries is believed to underlie pregnancy disorders, including preeclampsia and fetal growth retardation. Modern diagnostic methods such as capillaroscopy allow noninvasively assessing the state of the microcirculatory system. The risk of infection of the fetus and newborn is influenced by the microbiome of a pregnant woman, changes in which can lead to a decrease in adaptive immunity, vascular dysfunction and eclampsia. The results of the conducted studies indicate that arterial hypertension in pregnant women is associated with the risk of premature birth and low birth weight, placental insufficiency, neutropenia of newborns, changes in the microbiome, and microcirculatory disorders. Each of these factors increases the risk of neonatal sepsis and affects the outcome of the disease. Blood pressure monitoring can be considered as a preventive measure not only for eclampsia and other complications of pregnancy and childbirth, but also for the prevention of neonatal sepsis.
- 20 November 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 18,p. 188-193
Comparative analysis of audiological parameters in children with auditory neuropathy spectrum disorders of various etiologies
Aim. To conduct a comparative analysis of the audiological profile of patients to develop criteria for the early diagnosis of ANSD. Materials and methods. A total of 21 children with hearing impairment (mean age 6.25 ± 4.15 years) were examined. All patients underwent clinical, audiological, and molecular genetic testing. Based on the genetic testing results, the patients were divided into two groups: Group 1 (12 children) – with genetically determined forms of ANSD, and Group 2 (9 children) – with other etiological factors. Results and discussion. According to the molecular genetic testing results, nucleotide sequence variants were identified in the genes OTOF (24%), CDH23, TMC1, COL11A1, PRPS1, and HOMER2 in 12 (57%) children with ANSD; eight of these variants were previously unreported. All patients with OTOF -associated ANSD exhibited present transient evoked otoacoustic emissions (TEOAEs), unlike the other groups. Statistically significant differences were found in otoacoustic emission parameters and the discrepancy between audiometry and ASSR test results among the ANSD groups. In our study, parents of children with genetically caused hearing loss reported a higher quality of life than parents of patients with ANSD of other etiologies. Conclusions. Despite the genetic heterogeneity of ANSD, pathogenic variants in the OTOF gene played a leading etiological role. The presence of TEOAE is a specific marker for OTOF-mediated ANSD. The study results confirm that the implementation of an integrated molecular-genetic and audiological diagnostic workup is a necessary condition for the verification of ANSD subtypes and the development of personalized rehabilitation measures tailored to the disease etiology.
- 20 November 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 18,p. 188-193
Comparative analysis of audiological parameters in children with auditory neuropathy spectrum disorders of various etiologies
Aim. To conduct a comparative analysis of the audiological profile of patients to develop criteria for the early diagnosis of ANSD. Materials and methods. A total of 21 children with hearing impairment (mean age 6.25 ± 4.15 years) were examined. All patients underwent clinical, audiological, and molecular genetic testing. Based on the genetic testing results, the patients were divided into two groups: Group 1 (12 children) – with genetically determined forms of ANSD, and Group 2 (9 children) – with other etiological factors. Results and discussion. According to the molecular genetic testing results, nucleotide sequence variants were identified in the genes OTOF (24%), CDH23, TMC1, COL11A1, PRPS1, and HOMER2 in 12 (57%) children with ANSD; eight of these variants were previously unreported. All patients with OTOF -associated ANSD exhibited present transient evoked otoacoustic emissions (TEOAEs), unlike the other groups. Statistically significant differences were found in otoacoustic emission parameters and the discrepancy between audiometry and ASSR test results among the ANSD groups. In our study, parents of children with genetically caused hearing loss reported a higher quality of life than parents of patients with ANSD of other etiologies. Conclusions. Despite the genetic heterogeneity of ANSD, pathogenic variants in the OTOF gene played a leading etiological role. The presence of TEOAE is a specific marker for OTOF-mediated ANSD. The study results confirm that the implementation of an integrated molecular-genetic and audiological diagnostic workup is a necessary condition for the verification of ANSD subtypes and the development of personalized rehabilitation measures tailored to the disease etiology.
- 30 August 2025
- Published by Alfmed LLC in Medical alphabet
- No. 17,p. 21-26
Microcirculation disorders in hypertensive disorders in pregnant women
Arterial hypertension poses a threat to both the pregnant woman and the health of the newborn. Vascular disorders play an important role in the pathogenesis of hypertension. A study of microcirculation in arterial hypertension was conducted with the inclusion of 42 women with newly diagnosed or untreated arterial hypertension of grade 1–2 and a control group. Microcirculation was studied by capillaroscopy of the nail bed. The revealed changes in the microcirculatory system in women with arterial hypertension compared with patients without arterial hypertension included changes in the density of the capillary network in the form of rarefaction, degree of tortuosity, enlargement of the perivascular zone, arterial capillaries, venous capillaries, diameter of the transitional capillaries. The study of the prevalence of complications of pregnancy and childbirth in arterial hypertension of pregnant women, as well as its effect on the condition of the newborn. The analysis of 150 SMADS of pregnant women and information from EMIAS was carried out. The prevalence of hypertensive disorders among pregnant women was 19.3%. 69% of pregnant women with hypertension had this disease before pregnancy. An analysis of the complications of current pregnancy in hypertensive disorders showed a high percentage of the incidence of preeclampsia or a high risk of its development (41.38%). The incidence of preeclampsia and a high risk of its development in women without hypertension was 5.3%. Among the complications of pregnancy with hypertension, the following were identified: gestational diabetes mellitus – 31%, anemia of varying severity – 17.2%, gestational hypertension – 10.3%, toxicosis – 6.9%, threat of premature birth – 3.5%, gestational pyelonephritis – 3.5%. When assessing the relationship between hypertension and complications in childbirth, the following data were obtained: preterm birth – 16.7%, cesarean delivery – 47.4%, premature discharge of amniotic fluid/membranes – 21.1%, ruptures of the cervix/perineum – 21.1%, vacuum extraction of the fetus – 5.2%, fetal distress – 10.5%. the birth of children with a height of less than 45 cm and weighing less than 2500 g – 10.5%. The data we obtained coincided with the results of most studies that revealed a high risk of pregnancy and childbirth complications in pregnant women with hypertension. Prediction of arterial hypertension during pregnancy. it is an urgent task. Methods for studying microcirculation are available and can be used for screening surveillance to identify women at risk of hypertensive pregnancy complications at the planning stage.
- 30 August 2025
- Published by Alfmed LLC in Medical alphabet
- No. 17,p. 21-26
Microcirculation disorders in hypertensive disorders in pregnant women
Arterial hypertension poses a threat to both the pregnant woman and the health of the newborn. Vascular disorders play an important role in the pathogenesis of hypertension. A study of microcirculation in arterial hypertension was conducted with the inclusion of 42 women with newly diagnosed or untreated arterial hypertension of grade 1–2 and a control group. Microcirculation was studied by capillaroscopy of the nail bed. The revealed changes in the microcirculatory system in women with arterial hypertension compared with patients without arterial hypertension included changes in the density of the capillary network in the form of rarefaction, degree of tortuosity, enlargement of the perivascular zone, arterial capillaries, venous capillaries, diameter of the transitional capillaries. The study of the prevalence of complications of pregnancy and childbirth in arterial hypertension of pregnant women, as well as its effect on the condition of the newborn. The analysis of 150 SMADS of pregnant women and information from EMIAS was carried out. The prevalence of hypertensive disorders among pregnant women was 19.3%. 69% of pregnant women with hypertension had this disease before pregnancy. An analysis of the complications of current pregnancy in hypertensive disorders showed a high percentage of the incidence of preeclampsia or a high risk of its development (41.38%). The incidence of preeclampsia and a high risk of its development in women without hypertension was 5.3%. Among the complications of pregnancy with hypertension, the following were identified: gestational diabetes mellitus – 31%, anemia of varying severity – 17.2%, gestational hypertension – 10.3%, toxicosis – 6.9%, threat of premature birth – 3.5%, gestational pyelonephritis – 3.5%. When assessing the relationship between hypertension and complications in childbirth, the following data were obtained: preterm birth – 16.7%, cesarean delivery – 47.4%, premature discharge of amniotic fluid/membranes – 21.1%, ruptures of the cervix/perineum – 21.1%, vacuum extraction of the fetus – 5.2%, fetal distress – 10.5%. the birth of children with a height of less than 45 cm and weighing less than 2500 g – 10.5%. The data we obtained coincided with the results of most studies that revealed a high risk of pregnancy and childbirth complications in pregnant women with hypertension. Prediction of arterial hypertension during pregnancy. it is an urgent task. Methods for studying microcirculation are available and can be used for screening surveillance to identify women at risk of hypertensive pregnancy complications at the planning stage.
- Open Access
- 3 April 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 94-102
The role of topical therapy in the complex treatment of tonsillopharyngitis in children
Acute tonsillopharyngitis is a common disease (2–5% of paediatric outpatient visits) for which systemic antimicrobials are often prescribed. However, streptococcal tonsillopharyngitis, infection caused by group A beta-hemolytic streptococci (GABHS), is one of the main indications for antibiotic therapy in acute tonsillopharyngitis in children. When developing a treatment regimen for the disease, preference is given to topical therapy (except in cases of streptococcal tonsillopharyngitis), and the topical antimicrobial therapy methodology recognises that laryngospasm may occur in young children, and the microbiome of the oral cavity and pharynx may need correction in frequently ill children after intensive antimicrobial therapy. Aerosol therapy in the form of inhalation of pharmacological agents that have higher chemical and physical activity than their liquid counterparts due to larger total surface area of the dispersed phase is the optimal method for delivering pharmacological agents into the oral cavity and pharynx. In recent years, a new generation antiseptic benzyldimethyl-myristoylamino-propylammonium chloride has become increasingly common. It showed pronounced activity against Gram-positive and Gram-negative bacteria, fungi, complex viruses, including the SARS-CoV-2 coronavirus, protozoa, aerobic, anaerobic flora in the form of monocultures and microbial associations, including strains with multiple antibiotic resistance. This antiseptic agent refers to drugs of low-toxicity, and does not have any local irritating, allergenic, mutagenic, carcinogenic or embryotoxic effect. It has been identified as having immunoadjuvant effect. The review of clinical observations showed that an aerosolized form of benzyldimethyl-myristoylaminopropylammonium chloride had a favourable clinical effect in patients with tonsillopharyngitis of both streptococcal and other, in particular viral, etiology. The aerosolized form of the drug provides a wide spray angle and finely dispersed diffusion, as opposed to a spraying device, due to which the drops of the drug cover the mucous membrane in a more accurate way. The findings of the analysis of systematic reviews on the etiology, clinical picture and diagnosis of acute tonsillopharyngitis, updates on the oropharynx microbiocenosis and methods for its correction, and clinical studies on the efficacy and safety of the aerosolized form of benzyldimethyl-myristoylamino-propylammonium chloride have led to the conclusion that its application as topical therapy is useful for the treatment of acute tonsillopharyngitis in children.
- 3 April 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 1,p. 94-102
Open AccessThe role of topical therapy in the complex treatment of tonsillopharyngitis in children
Acute tonsillopharyngitis is a common disease (2–5% of paediatric outpatient visits) for which systemic antimicrobials are often prescribed. However, streptococcal tonsillopharyngitis, infection caused by group A beta-hemolytic streptococci (GABHS), is one of the main indications for antibiotic therapy in acute tonsillopharyngitis in children. When developing a treatment regimen for the disease, preference is given to topical therapy (except in cases of streptococcal tonsillopharyngitis), and the topical antimicrobial therapy methodology recognises that laryngospasm may occur in young children, and the microbiome of the oral cavity and pharynx may need correction in frequently ill children after intensive antimicrobial therapy. Aerosol therapy in the form of inhalation of pharmacological agents that have higher chemical and physical activity than their liquid counterparts due to larger total surface area of the dispersed phase is the optimal method for delivering pharmacological agents into the oral cavity and pharynx. In recent years, a new generation antiseptic benzyldimethyl-myristoylamino-propylammonium chloride has become increasingly common. It showed pronounced activity against Gram-positive and Gram-negative bacteria, fungi, complex viruses, including the SARS-CoV-2 coronavirus, protozoa, aerobic, anaerobic flora in the form of monocultures and microbial associations, including strains with multiple antibiotic resistance. This antiseptic agent refers to drugs of low-toxicity, and does not have any local irritating, allergenic, mutagenic, carcinogenic or embryotoxic effect. It has been identified as having immunoadjuvant effect. The review of clinical observations showed that an aerosolized form of benzyldimethyl-myristoylaminopropylammonium chloride had a favourable clinical effect in patients with tonsillopharyngitis of both streptococcal and other, in particular viral, etiology. The aerosolized form of the drug provides a wide spray angle and finely dispersed diffusion, as opposed to a spraying device, due to which the drops of the drug cover the mucous membrane in a more accurate way. The findings of the analysis of systematic reviews on the etiology, clinical picture and diagnosis of acute tonsillopharyngitis, updates on the oropharynx microbiocenosis and methods for its correction, and clinical studies on the efficacy and safety of the aerosolized form of benzyldimethyl-myristoylamino-propylammonium chloride have led to the conclusion that its application as topical therapy is useful for the treatment of acute tonsillopharyngitis in children.
- 5 December 2024
- Published by Alfmed LLC in Medical alphabet
- No. 24,p. 11-15
Arterial hypertension in pregnant women – diagnosis and features of therapy
Hypertension in pregnancy is one of the most common pathology in the structure of extragenital deseases in pregnant women. Cardiovascular diseases, including strokes, account for approximately half of all cases of maternal mortality. In addition, hypertension and its complications are significant cause of fetal and infant mortality. The prevalence of this pathology increase over the past few decades. Hypertension and its complications significantly worsen the prognosis for both the mother and the fetus and newborn. Hypertension in pregnancy also causes the cardiovascular pathology in the future. Early diagnosis and adequate therapy of hypertension at all stages of preparation and the pregnancy can significantly improve the prognosis for the mother and fetus/newborn, as well as prevent possible cardiovascular diseases and complications in women in the future.
- 5 December 2024
- Published by Alfmed LLC in Medical alphabet
- No. 24,p. 11-15
Arterial hypertension in pregnant women – diagnosis and features of therapy
Hypertension in pregnancy is one of the most common pathology in the structure of extragenital deseases in pregnant women. Cardiovascular diseases, including strokes, account for approximately half of all cases of maternal mortality. In addition, hypertension and its complications are significant cause of fetal and infant mortality. The prevalence of this pathology increase over the past few decades. Hypertension and its complications significantly worsen the prognosis for both the mother and the fetus and newborn. Hypertension in pregnancy also causes the cardiovascular pathology in the future. Early diagnosis and adequate therapy of hypertension at all stages of preparation and the pregnancy can significantly improve the prognosis for the mother and fetus/newborn, as well as prevent possible cardiovascular diseases and complications in women in the future.
- 14 June 2024
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 103 (3)
CLINICAL CASE OF PYODERMA GANGRENOSUM IN A FEMALE ADOLESCENT
Pyoderma gangrenosum (PG) is the most severe type of pyoderma and is extremely rare among children and adolescents. Authors represent a clinical case of PG in a 14 years old female adolescent characterized by multiple sharply painful ulcerative defects with a pronounced tendency to peripheral growth. PG had arisen and proceeded further during the postoperative period against the background of iron deficiency anemia, chronic nonspecific nonulcerative colitis and a dysfunctional state of humoral immunity. Making a diagnosis, conducting differential diagnostics, identifying provoking factors, searching for concomitant somatic pathology, using a set of therapeutic measures made possible eliminating the PG clinical manifestations completely though development of the preventive measures and determination of the prognosis of the disease are difficult clinical tasks for pediatric practitioners nowadays.
- 14 June 2024
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 103 (3)
CLINICAL CASE OF PYODERMA GANGRENOSUM IN A FEMALE ADOLESCENT
Pyoderma gangrenosum (PG) is the most severe type of pyoderma and is extremely rare among children and adolescents. Authors represent a clinical case of PG in a 14 years old female adolescent characterized by multiple sharply painful ulcerative defects with a pronounced tendency to peripheral growth. PG had arisen and proceeded further during the postoperative period against the background of iron deficiency anemia, chronic nonspecific nonulcerative colitis and a dysfunctional state of humoral immunity. Making a diagnosis, conducting differential diagnostics, identifying provoking factors, searching for concomitant somatic pathology, using a set of therapeutic measures made possible eliminating the PG clinical manifestations completely though development of the preventive measures and determination of the prognosis of the disease are difficult clinical tasks for pediatric practitioners nowadays.
- 13 May 2024
- Published by Alfmed LLC in Medical alphabet
- No. 13,p. 7-13
Phytotherapy for stress in children from the age of three
Mental and behavioral disorders begin in early childhood, affect the quality of life of children and their parents, can lead to changes in brain development and function, and somatic diseases. Stress in young children can be associated with frightening changes in their lives – going to kindergarten, school. Treatment of mental disorders in childhood requires a comprehensive approach, including elimination of the causes of disorders, lifestyle modification, psychological and medical support. Phytotherapy is an effective treatment method accepted in most countries and characterized by a low risk of adverse events, which makes it indispensable in pediatric practice. The article describes the characteristics of medicinal plants used for the treatment of mental disorders. A review of clinical studies confirming the efficacy and safety of phytotherapy is presented. A tactical approach to the use of medicinal plant-based drugs in the practice of a pediatrician is considered.
- 13 May 2024
- Published by Alfmed LLC in Medical alphabet
- No. 13,p. 7-13
Phytotherapy for stress in children from the age of three
Mental and behavioral disorders begin in early childhood, affect the quality of life of children and their parents, can lead to changes in brain development and function, and somatic diseases. Stress in young children can be associated with frightening changes in their lives – going to kindergarten, school. Treatment of mental disorders in childhood requires a comprehensive approach, including elimination of the causes of disorders, lifestyle modification, psychological and medical support. Phytotherapy is an effective treatment method accepted in most countries and characterized by a low risk of adverse events, which makes it indispensable in pediatric practice. The article describes the characteristics of medicinal plants used for the treatment of mental disorders. A review of clinical studies confirming the efficacy and safety of phytotherapy is presented. A tactical approach to the use of medicinal plant-based drugs in the practice of a pediatrician is considered.